PATENT CLAIM ANALYSIS

Application Number: 15937599
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["544", "279000"]

Abstract:
The invention discloses a screening method for the identification of new compounds for use in the treatment of cancer.

Claim (Index 1):
A method for the prophylaxis or treatment of cancer in a subject in need thereof comprising administering to the subject an effective amount of a compound, wherein the compound modifies splicing of the FoxM1 gene and induces a transcriptionally inactive FoxM1 variant.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.17647
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15048653', '13980565', '14036879', '12673432', '13840092']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7061250406989413
- 35 USC 102 Novelty (BERT): 0.6351816555623055
- Combined Prediction Score: 0.6990307021852777
- Mean Citation Score: 331.039194
- Max Citation Score: 682.5115
- Similarity Product: 523.2665351809859

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test